This page has only limited features, please log in for full access.
Sheldon Krimsky. Review of Three Books on Science: Trust, Corporate Influence, and Militarization. Science, Technology, & Human Values 2021, 1 .
AMA StyleSheldon Krimsky. Review of Three Books on Science: Trust, Corporate Influence, and Militarization. Science, Technology, & Human Values. 2021; ():1.
Chicago/Turabian StyleSheldon Krimsky. 2021. "Review of Three Books on Science: Trust, Corporate Influence, and Militarization." Science, Technology, & Human Values , no. : 1.
Glyphosate-based herbicides (GBHs) have become the leading agricultural herbicides used globally since the development of genetically engineered herbicide-tolerant crops. This paper investigates whether GBHs are consistent with or supportive of sustainable agriculture. Agricultural sustainability is defined by generally agreed upon goals: 1) promoting agroecology; 2) protecting soils and the Earth’s natural resources; 3) protecting biodiversity; and 4) enhancing the quality of life and health of farmers, farm workers, and society. Through an in-depth examination of the scholarly literature, the paper explores whether the scientific studies of GBHs are consistent with their sustainable applications in agriculture in the areas of human health, non-tillage agriculture, soil quality, aquatic ecosystems and beneficial, non-target species. Based on the four generally agreed upon goals listed above for agricultural sustainability, the paper finds that GBHs are not consistent with sustainability goals.
Sheldon Krimsky. Can Glyphosate-Based Herbicides Contribute to Sustainable Agriculture? Sustainability 2021, 13, 2337 .
AMA StyleSheldon Krimsky. Can Glyphosate-Based Herbicides Contribute to Sustainable Agriculture? Sustainability. 2021; 13 (4):2337.
Chicago/Turabian StyleSheldon Krimsky. 2021. "Can Glyphosate-Based Herbicides Contribute to Sustainable Agriculture?" Sustainability 13, no. 4: 2337.
Sheldon Krimsky. Book review of “Bioethics in Action” Cambridge University Press. Accountability in Research 2021, 1 -3.
AMA StyleSheldon Krimsky. Book review of “Bioethics in Action” Cambridge University Press. Accountability in Research. 2021; ():1-3.
Chicago/Turabian StyleSheldon Krimsky. 2021. "Book review of “Bioethics in Action” Cambridge University Press." Accountability in Research , no. : 1-3.
Sheldon Krimsky. Disguised Academic Plagiarism. A typology and case studies for researchers and editors. Research ethics forum 8. Accountability in Research 2020, 28, 44 -46.
AMA StyleSheldon Krimsky. Disguised Academic Plagiarism. A typology and case studies for researchers and editors. Research ethics forum 8. Accountability in Research. 2020; 28 (1):44-46.
Chicago/Turabian StyleSheldon Krimsky. 2020. "Disguised Academic Plagiarism. A typology and case studies for researchers and editors. Research ethics forum 8." Accountability in Research 28, no. 1: 44-46.
Sheldon Krimsky. The Moral Choices on CRISPR Babies. The American Journal of Bioethics 2019, 19, 15 -16.
AMA StyleSheldon Krimsky. The Moral Choices on CRISPR Babies. The American Journal of Bioethics. 2019; 19 (10):15-16.
Chicago/Turabian StyleSheldon Krimsky. 2019. "The Moral Choices on CRISPR Babies." The American Journal of Bioethics 19, no. 10: 15-16.
This paper reviews the court-released discovery documents obtained from litigation against Monsanto over its herbicide Roundup and through Freedom of Information Act requests (requests to regulatory agencies and public universities in the United States). We sought evidence of corporate malfeasance and undisclosed conflicts of interest with respect to issues of scientific integrity. The findings include evidence of ghostwriting, interference in journal publication, and undue influence of a federal regulatory agency.
Sheldon Krimsky; Carey Gillam. Roundup litigation discovery documents: implications for public health and journal ethics. Journal of Public Health Policy 2018, 39, 318 -326.
AMA StyleSheldon Krimsky, Carey Gillam. Roundup litigation discovery documents: implications for public health and journal ethics. Journal of Public Health Policy. 2018; 39 (3):318-326.
Chicago/Turabian StyleSheldon Krimsky; Carey Gillam. 2018. "Roundup litigation discovery documents: implications for public health and journal ethics." Journal of Public Health Policy 39, no. 3: 318-326.
After 40 years, the 1976 US Toxic Substances Control Act (TSCA) was revised under the Frank R. Lautenberg Chemical Safety for the 21st Century Act. Its original goals of protecting the public from hazardous chemicals were hindered by complex and cumbersome administrative burdens, data limitations, vulnerabilities in risk assessments, and recurring corporate lawsuits. As a result, countless chemicals were entered into commercial use without toxicological information. Few chemicals of the many identified as potential public health threats were regulated or banned. This paper explores the factors that have worked against a comprehensive and rational policy for regulating toxic chemicals and discusses whether the TSCA revisions offer greater public protection against existing and new chemicals.
Sheldon Krimsky. The unsteady state and inertia of chemical regulation under the US Toxic Substances Control Act. PLOS Biology 2017, 15, e2002404 .
AMA StyleSheldon Krimsky. The unsteady state and inertia of chemical regulation under the US Toxic Substances Control Act. PLOS Biology. 2017; 15 (12):e2002404.
Chicago/Turabian StyleSheldon Krimsky. 2017. "The unsteady state and inertia of chemical regulation under the US Toxic Substances Control Act." PLOS Biology 15, no. 12: e2002404.
Sheldon Krimsky. If the "Physician Payments Sunshine Act" Is a Solution, What Is the Problem? The American Journal of Bioethics 2017, 17, 29 -30.
AMA StyleSheldon Krimsky. If the "Physician Payments Sunshine Act" Is a Solution, What Is the Problem? The American Journal of Bioethics. 2017; 17 (6):29-30.
Chicago/Turabian StyleSheldon Krimsky. 2017. "If the "Physician Payments Sunshine Act" Is a Solution, What Is the Problem?" The American Journal of Bioethics 17, no. 6: 29-30.
The National Academies of Sciences, Engineering and Medicine (NASEM) publishes numerous reports each year that are received with high esteem by the scientific community and public policy makers. The NASEM has internal standards for selecting committee members that author its reports, mostly from academia, and vetting conflicts of interest. This study examines whether there were any financial conflicts of interest (COIs) among the twenty invited committee members who wrote the 2016 report on genetically engineered (GE) crops. Our results showed that six panel members had one or more reportable financial COIs, none of which were disclosed in the report. We also report on institutional COIs held by the NASEM related to the report. The difference between our findings and the NASEM reporting standards are discussed.
Sheldon Krimsky; Tim Schwab. Conflicts of interest among committee members in the National Academies’ genetically engineered crop study. PLOS ONE 2017, 12, e0172317 .
AMA StyleSheldon Krimsky, Tim Schwab. Conflicts of interest among committee members in the National Academies’ genetically engineered crop study. PLOS ONE. 2017; 12 (2):e0172317.
Chicago/Turabian StyleSheldon Krimsky; Tim Schwab. 2017. "Conflicts of interest among committee members in the National Academies’ genetically engineered crop study." PLOS ONE 12, no. 2: e0172317.
Sheldon Krimsky. Clinical Research Involving Pregnant Women. Accountability in Research 2017, 24, 327 -328.
AMA StyleSheldon Krimsky. Clinical Research Involving Pregnant Women. Accountability in Research. 2017; 24 (5):327-328.
Chicago/Turabian StyleSheldon Krimsky. 2017. "Clinical Research Involving Pregnant Women." Accountability in Research 24, no. 5: 327-328.
Sheldon Krimsky. Sugar Industry Science and Heart Disease. Accountability in Research 2016, 24, 124 -125.
AMA StyleSheldon Krimsky. Sugar Industry Science and Heart Disease. Accountability in Research. 2016; 24 (2):124-125.
Chicago/Turabian StyleSheldon Krimsky. 2016. "Sugar Industry Science and Heart Disease." Accountability in Research 24, no. 2: 124-125.
Prominent scientists and policymakers assert with confidence that there is no scientific controversy over the health effects of genetically modified organisms (GMOs)—that genetically modified crops currently in commercial use and those yet to be commercialized are inherently safe for human consumption and do not have to be tested. Those who disagree are cast as “GMO deniers.” This article examines scientific reviews and papers on GMOs, compares the findings of professional societies, and discusses the treatment of scientists who have reported adverse effects in animal feeding experiments. This article concludes by exploring the role that politics and corporate interests have had in distorting an honest inquiry into the health effects of GMO crops.
Sheldon Krimsky. An Illusory Consensus behind GMO Health Assessment. Science, Technology, & Human Values 2015, 40, 883 -914.
AMA StyleSheldon Krimsky. An Illusory Consensus behind GMO Health Assessment. Science, Technology, & Human Values. 2015; 40 (6):883-914.
Chicago/Turabian StyleSheldon Krimsky. 2015. "An Illusory Consensus behind GMO Health Assessment." Science, Technology, & Human Values 40, no. 6: 883-914.
Sheldon Krimsky. The dilemma in regulating drug advertising: propositional versus nonpropositional content. The American Journal of Bioethics 2013, 13, 16 -7.
AMA StyleSheldon Krimsky. The dilemma in regulating drug advertising: propositional versus nonpropositional content. The American Journal of Bioethics. 2013; 13 (5):16-7.
Chicago/Turabian StyleSheldon Krimsky. 2013. "The dilemma in regulating drug advertising: propositional versus nonpropositional content." The American Journal of Bioethics 13, no. 5: 16-7.
Sheldon Krimsky. Genetic causation: a cross disciplinary inquiry. Advances in Child Development and Behavior Volume 32 2013, 44, 1 .
AMA StyleSheldon Krimsky. Genetic causation: a cross disciplinary inquiry. Advances in Child Development and Behavior Volume 32. 2013; 44 ():1.
Chicago/Turabian StyleSheldon Krimsky. 2013. "Genetic causation: a cross disciplinary inquiry." Advances in Child Development and Behavior Volume 32 44, no. : 1.
This commentary discusses how ethicists view the responsibilities of corporations, of their philanthropic spin-offs, and of not-for-profit organizations with regard to use of monies from corporate philanthropies for public health. Article JPHP.2012.60 available at www.palgrave-journals.com/jphp/, relates to this commentary.
Sheldon Krimsky. Commentary: Corporate philanthropy and conflicts of interest in public health. Journal of Public Health Policy 2012, 34, 137 -9.
AMA StyleSheldon Krimsky. Commentary: Corporate philanthropy and conflicts of interest in public health. Journal of Public Health Policy. 2012; 34 (1):137-9.
Chicago/Turabian StyleSheldon Krimsky. 2012. "Commentary: Corporate philanthropy and conflicts of interest in public health." Journal of Public Health Policy 34, no. 1: 137-9.
In the mid-1980s, social scientists compared outcome measures of related drug studies, some funded by private companies and others by nonprofit organizations or government agencies. The concept of a “funding effect” was coined when it was discovered that study outcomes could be statistically correlated with funding sources, largely in drug safety and efficacy studies. Also identified in tobacco research and chemical toxicity studies, the “funding effect” is often attributed, implicitly or explicitly, to research bias. This article discusses the meaning of scientific bias in research, examines the strongest evidence for the “funding effect,” and explores the question of whether the “funding effect” is an indicator of biased research that is driven by the financial interests of the for-profit sponsor. This article argues that the “funding effect” is merely a symptom of the factors that could be responsible for outcome disparities in product assessment. Social scientists should not suspend their skepticism and choose as a default hypothesis that bias is always or typically the cause.
Sheldon Krimsky. Do Financial Conflicts of Interest Bias Research? Science, Technology, & Human Values 2012, 38, 566 -587.
AMA StyleSheldon Krimsky. Do Financial Conflicts of Interest Bias Research? Science, Technology, & Human Values. 2012; 38 (4):566-587.
Chicago/Turabian StyleSheldon Krimsky. 2012. "Do Financial Conflicts of Interest Bias Research?" Science, Technology, & Human Values 38, no. 4: 566-587.
The headlines back in June, 2005, read “FDA approves a heart drug for African Americans”. The decision that gave the company NitroMed approval for its drug BiDil exclusively to a “racial group” represented a milestone in US drug policy. The decision ignited a debate that polarised the African American community, confounded proponents of personalised medicine, and dismayed groups opposed to reinscribing racial categories into science. Ever since Ashley Montagu published Man's Most Dangerous Myth: The Fallacy of Race in 1964, scientists have reached a broad consensus that “race” applied to human populations has no standing in science.
Sheldon Krimsky. The short life of a race drug. The Lancet 2012, 379, 114 -115.
AMA StyleSheldon Krimsky. The short life of a race drug. The Lancet. 2012; 379 (9811):114-115.
Chicago/Turabian StyleSheldon Krimsky. 2012. "The short life of a race drug." The Lancet 379, no. 9811: 114-115.
Nature - the world's best science and medicine on your desktop
Sheldon Krimsky. Beware of gifts that come at too great a cost. Nature 2011, 474, 129 -129.
AMA StyleSheldon Krimsky. Beware of gifts that come at too great a cost. Nature. 2011; 474 (7350):129-129.
Chicago/Turabian StyleSheldon Krimsky. 2011. "Beware of gifts that come at too great a cost." Nature 474, no. 7350: 129-129.
Sheldon Krimsky. Technocapitalism: A Critical Perspective on Technological Innovation and Corporatism. Contemporary Sociology: A Journal of Reviews 2010, 39, 609 -611.
AMA StyleSheldon Krimsky. Technocapitalism: A Critical Perspective on Technological Innovation and Corporatism. Contemporary Sociology: A Journal of Reviews. 2010; 39 (5):609-611.
Chicago/Turabian StyleSheldon Krimsky. 2010. "Technocapitalism: A Critical Perspective on Technological Innovation and Corporatism." Contemporary Sociology: A Journal of Reviews 39, no. 5: 609-611.
Basic science and medical journals are increasingly requiring authors to disclose financial interests they have in the subject matter of contributed articles and letters. A comparison of journal conflict-of-interest (COI) policies can provide insight into published reports of low compliance rates and inconsistencies in disclosures by the same author found in different journals. The objective of this article is to compare the criteria, specificity, and scope of COI polices in toxicology and medical journals. We studied the COI policies of 47 toxicology and 180 medical journals catalogued in Ulrich's International Periodicals Directory for criteria of competing interests, types of submissions covered, monetary or time thresholds for reporting, and penalties for violations. Indicators were constructed for rating policy specificity, author discretion, and policy scope. Written COI policies were found in 87% if the toxicology and 84% of the medical journals; 15% and 28% of the toxicology and medical journals, respectively, were explicit about the type of content covered by the policy; 20% and 29%, respectively, included a monetary threshold for reporting purposes; the level of author discretion for reporting COIs was found to be high in 46% of the toxicology and 41% of the medical journals respectively. The level of specificity for more than 75% of the written journal COI policies for both fields was minimal or practically nil, and the scope of more than 80% of the policies was minimal to narrow. Lack of specificity, high author discretion, and restricted scope were found to be prevalent among COI policies of toxicology and medical journals.
Sheldon Krimsky; Erin Sweet. An Analysis of Toxicology and Medical Journal Conflict-of-Interest Polices. Accountability in Research 2009, 16, 235 -253.
AMA StyleSheldon Krimsky, Erin Sweet. An Analysis of Toxicology and Medical Journal Conflict-of-Interest Polices. Accountability in Research. 2009; 16 (5):235-253.
Chicago/Turabian StyleSheldon Krimsky; Erin Sweet. 2009. "An Analysis of Toxicology and Medical Journal Conflict-of-Interest Polices." Accountability in Research 16, no. 5: 235-253.